{
    "id": "0699",
    "question": "A 25-year-old female presents to her primary care physician complaining of double vision. She first started seeing double after a long day at her work as a radiation technologist. Since then, her vision has appeared to worsen in the evenings. She has also felt worsening fatigue despite no change in her work hours or sleep habits. She has a history of type I diabetes mellitus and her most recent hemoglobin A1c was 7.4%. Her family history is notable for Sjogren\u2019s syndrome in her mother and hypertension, hyperlipidemia, and carotid dissection in her father. Her temperature is 98.9\u00b0F (37.2\u00b0C), blood pressure is 105/70 mmHg, pulse is 75/min, and respirations are 16/min. On examination, her pupils are equally round and reactive to light. Extraocular movements are intact. Mild ptosis is noted bilaterally but worse on the left. A visual acuity test reveals no abnormalities. Which of the following medications is most appropriate in the management of this patient?",
    "options": {
        "A": "Pyridostigmine",
        "B": "Physostigmine",
        "C": "Hydrocortisone",
        "D": "Azathioprine"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To approach this patient's case, we need to consider several factors including her symptoms, medical history, and physical examination findings. The patient presents with double vision that worsens in the evenings, which could be indicative of myasthenia gravis (MG), an autoimmune disorder that affects the neuromuscular junction. Her history of type I diabetes mellitus and family history of Sjogren's syndrome also support this possibility. The presence of mild ptosis bilaterally, especially worse on the left, is consistent with MG. The patient's visual acuity test shows no abnormalities, which rules out other causes of double vision such as cataracts or optic neuritis. The intact extraocular movements and equally round pupils suggest that the cranial nerves are not affected. Considering the patient's symptoms and physical examination findings, the most likely diagnosis is myasthenia gravis. Now, let's consider the treatment options provided: A. Pyridostigmine is a cholinesterase inhibitor that increases acetylcholine levels at the neuromuscular junction, which is the primary mechanism of action for treating myasthenia gravis. It is the most appropriate choice for this patient. B. Physostigmine is also a cholinesterase inhibitor, but it is primarily used to treat glaucoma, urinary retention, and anticholinergic toxicity. It is not the first-line treatment for myasthenia gravis. C. Hydrocortisone is a corticosteroid that can be used to treat myasthenia gravis, but it is typically used in patients who do not respond to or cannot tolerate cholinesterase inhibitors. D. Azathioprine is an immunosuppressive medication that can be used to treat myasthenia gravis, but it is not the first-line treatment and is typically used in patients who do not respond to cholinesterase inhibitors or have severe disease. Therefore, the most appropriate medication in the management of this patient is Pyridostigmine.\", \"answer_choice\": \"A\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 65.41039252281189
}